MedTrace Logo

Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients

NCT03180398 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2023-10-12

Study results available
· View outcomes & findings →

Summary

This is a pilot study of implement multi-parametric MR imaging for organ delineation and tumor response assessment of prostate cancer patients being treated with radiation therapy.

Conditions

Interventions

DEVICE

Multiparametric MRI

MRI will be acquired before, during and after radiation treatment to evaluate treatment response

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-04
Primary Completion
2022-02-15
Completion
2022-02-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03180398 on ClinicalTrials.gov